There are aspects of the proposed Safe Cosmetics Modernization Act, introduced in the House Jan. 13, that are bound to be contentious. To understand their etiology one must go back in time to the dawning of cosmeceuticals and the regime of a more aggressive FDA than the cosmetics industry knows today.
Locke Lord attorney Sharon Blinkoff, general counsel for the Independent Cosmetic Manufacturers and Distributors, took the Rose Sheet on this journey in an interview
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?